Madrigal Pharmaceuticals Aktie
249,30
EUR
+1,80
EUR
+0,73
%
285,08
USD
+0,99
USD
+0,35
%
Werbung
Madrigal Pharmaceuticals Aktie Analyse
10.06.19 | Madrigal Pharmaceuticals Buy | B. Riley FBR | |
28.02.19 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
14.12.18 | Madrigal Pharmaceuticals Outperform | Wolfe Research | |
01.06.18 | Madrigal Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
01.06.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
30.01.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
06.12.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
29.11.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
Werbung
|
Werbung
Werbung